Use of a magnetic double J stent in pediatric patients: A case-control study at two Canadian pediatric centers

Alec Mitchell1, Stéphane Bolduc2, Katherine Moore2

  • 1Division of Urology, Alberta Children's Hospital, Calgary, Alberta, Canada.

Insights

Magnetic ureteral stents offer a safe and effective alternative for pediatric patients, reducing the need for general anesthesia during removal. This innovative approach shows promise for improved patient outcomes and healthcare efficiency.

Area of Science:

  • Pediatric Urology
  • Minimally Invasive Surgery
  • Medical Device Innovation

Background:

  • Ureteral stents with magnetic tips (Blackstar©) are newly approved in Canada.
  • Traditional stent procedures in children often require general anesthesia.
  • Magnetic stents offer potential benefits including cost savings, reduced operating room time, and decreased anesthetic exposure.

Purpose of the Study:

  • To evaluate the safety and efficacy of magnetic ureteral stents in pediatric patients.
  • To demonstrate the feasibility of non-anesthetic removal for magnetic stents.
  • To compare magnetic stent outcomes with traditional double J stents.

Main Methods:

  • A proof-of-concept pilot, case-control study conducted from May 2017 to May 2018.
  • Inclusion of pediatric patients undergoing ureteroscopy, ureteric re-implantation, and pyeloplasty.
  • Comparison of 40 patients with magnetic stents against 40 control patients with traditional double J stents.

Main Results:

  • Successful retrieval of 39 magnetic stents without general anesthesia.
  • A low retrieval failure rate of only 2.5% was observed.
  • Demonstrated comparable safety and efficacy to traditional ureteral stents.

Conclusions:

  • Magnetic ureteral stents are a safe and effective alternative for pediatric patients.
  • Non-anesthetic removal is feasible, with traditional cystoscopic removal as a fallback.
  • This technology can potentially minimize anesthetic exposure and healthcare costs in pediatric urology.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
276
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
203
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
262
Patient-centered Care01:13

Patient-centered Care

Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
2.9K
Brainstem: Control Centers of Medulla01:21

Brainstem: Control Centers of Medulla

The medulla oblongata is a crucial part of the brainstem responsible for controlling various autonomic and involuntary functions. It contains several nuclei, including the olivary, cuneate, gracile, and solitary nuclei.
Olivary Nucleus
The olivary nucleus, or inferior olivary nucleus, is located within the ventrolateral part of the medulla oblongata. It is primarily involved in motor coordination and motor learning. The olivary nucleus receives input from the spinal cord, cerebellum, and motor...
4.0K